KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Net Margin (2016 - 2025)

Historic Net Margin for Regeneron Pharmaceuticals (REGN) over the last 17 years, with Q4 2025 value amounting to 21.74%.

  • Regeneron Pharmaceuticals' Net Margin fell 24700.0% to 21.74% in Q4 2025 from the same period last year, while for Dec 2025 it was 31.41%, marking a year-over-year increase of 3400.0%. This contributed to the annual value of 31.41% for FY2025, which is 3400.0% up from last year.
  • According to the latest figures from Q4 2025, Regeneron Pharmaceuticals' Net Margin is 21.74%, which was down 24700.0% from 38.89% recorded in Q3 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Net Margin registered a high of 1947.0% during Q1 2022, and its lowest value of 21.74% during Q4 2025.
  • Its 5-year average for Net Margin is 189.22%, with a median of 36.95% in 2025.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Net Margin soared by 19029000bps in 2022, and later crashed by -19211400bps in 2023.
  • Regeneron Pharmaceuticals' Net Margin (Quarter) stood at 45.01% in 2021, then soared by 2559bps to 1197.1% in 2022, then plummeted by -97bps to 33.77% in 2023, then fell by -28bps to 24.22% in 2024, then fell by -10bps to 21.74% in 2025.
  • Its last three reported values are 21.74% in Q4 2025, 38.89% for Q3 2025, and 37.86% during Q2 2025.